Bristol-Myers Squibb Co. (NYSE:BMY)

Top Analyst Upgrades and Downgrades: Alibaba, Baidu, Bristol-Myers, Cimarex, Deere, Deutsche Bank, Micron, NeoPhotonics, Target, United Continental and More

Posted: May 20, 2019 at 8:45 am

Stocks were down another 0.6% or so in Dow Jones industrial average and S&P 500 futures on Monday morning as further realizations and expectations normalize into a belief that the ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Posted: May 10, 2019 at 10:15 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More

Posted: May 3, 2019 at 9:00 am

Stocks were indicated to open higher after a strong payrolls report on Friday morning. Despite a pullback this week, the markets remain near all-time highs and investors have solid double-digit ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Posted: April 26, 2019 at 8:45 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Posted: April 24, 2019 at 12:55 pm

When the stock market is hitting record highs, it's important to remember that it's really a market of stocks rather than a stock market. Not all companies are created equal. ...
Read Full Story »

Unbelievable Swings in Big Pharma Short Interest

Posted: April 10, 2019 at 9:40 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Sees a Few Wild Swings in Short Interest

Posted: March 27, 2019 at 8:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Posted: March 12, 2019 at 8:35 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Sees Tremendous Rise in Short Interest

Posted: February 28, 2019 at 8:30 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Scares Off Short Sellers

Posted: February 12, 2019 at 9:35 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Posted: January 29, 2019 at 3:01 pm

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options ...
Read Full Story »

Short Interest Spikes in a Couple Major Pharma Stocks

Posted: January 28, 2019 at 10:10 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

Posted: January 26, 2019 at 9:00 am

After one of the most brutal Decembers for stock investors in many years, we turned the calendar page on a new year. While the volatility did not go away, the ...
Read Full Story »

Why the Bristol-Myers Incredible Earnings Beat Is Getting Grounded

Posted: January 24, 2019 at 10:25 am

When Bristol-Myers Squibb Co. (NYSE: BMY) reported its most recent quarterly results before the markets opened on Thursday, the company said that it had $0.94 in earnings per share (EPS) ...
Read Full Story »

Major Pharma Sees Fading Short Interest

Posted: January 11, 2019 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »